For a while, there was a chance that the U.S. might eliminate Hepatitis C. Few new cases were showing up, and most of those infected with the virus were Baby Boomers who had been living with the disease for decades. Hopes really soared when the first medications hit the market that that could eliminate — not just manage — the infection.
Sammy Saab, a hepatologist at the David Geffen School of Medicine at UCLA, was one of the physicians who thought the U.S. might soon be rid of the liver-targeting disease. That is, until new data rolled in showing that Hepatitis C was far from gone. “This came as a big surprise to everybody,” Saab says.
